Clinical Trials
License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia Completed By RegeneRX
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration announced that it has...
Clinical Trials
Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing
Blake Insomnia Therapeutics Inc. , a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is excited to announce...
Clinical Trials
Titan pharmaceuticals receives fda clearance to begin clinical study of parkinson’s disease treatment
Titan Pharmaceuticals, Inc. announced that the U.S. FDA has cleared the Investigational New Drug (IND) application for its ropinirole implant intended for treatment of the...
Clinical Trials
Symic Bio Enrolls First Patient in MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Osteoarthritis
Symic Bio, a biopharmaceutical company developing novel matrix regulators,announced the treatment of the first patient in the MODIFY2 Phase 2 clinical trial investigating SB-061 for...
Articles
Driving Patient Engagement in Alzheimer’s Disease Clinical Research to Achieve Trial Success
Worldwide, around 47 million people have dementia, and there are 9.9 million new cases every year, according to recent data from the World Health Organization...
Articles
Solving Challenges and Pain Points for Complex Global Clinical Trials
Clinical trials are evolving away from trials based solely at investigator sites, moving on to the patient’s home, requiring direct-to-patient services in order for patients...
Articles
The Importance of the Human Touch in Improving Clinical Trial Patient-Centricity
Patient-centricity has become an important focus for drug developers and an essential element of clinical studies aimed at showing that a new therapy addresses real...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.